BFRI
Biofrontera Inc (BFRI)
Healthcare • NASDAQ • $0.80-2.14%
Key Fundamentals
- Symbol
- BFRI
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $0.80
- Daily Change
- -2.14%
- Market Cap
- $12.20M
- Trailing P/E
- N/A
- Forward P/E
- 1.91
- 52W High
- $1.66
- 52W Low
- $0.56
- Analyst Target
- $6.00
- Dividend Yield
- 0.00%
- Beta
- 0.88
About Biofrontera Inc
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Company websiteResearch BFRI on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.